The Effect of Low-dose Orlistat (60 mg Twice Daily) on Weight-loss and Markers of Metabolic Disease in Obese Subjects: A Preliminary Report
Maria Chiara Masoni, Elena Matteucci, Chiara Giampietro & Ottavio Giampietro · Journal of Scientific Research and Reports · 2014
Aims: The use of Orlistat as an aid for weight loss has increased among obese individuals over recent years. Although the most frequently administered dosage is 120 mg three times daily, data on the metabolic effects of this drug are inconclusive. The primary aim of the present s...
Open access
Research Article
10.9734/JSRR/2015/11168